AUS
NZ
UK
CA
USA
IND
Excite Technology Services Ltd (ASX:EXT) has informed the market of its intention to issue 100 million unlisted options with an exercise price of $0.01 each, expiring 36 months after issuance. These options will be granted as part-payment for capital raising services. The update, lodged on 3 July 2026, states that the issuance is conditional on shareholder approval, with both the approval meeting and proposed issue date scheduled for 31 August 2026. This development indicates EXT is actively pursuing a capital raising, with the options serving as a fee component for the intermediary or adviser involved. Investors are advised to monitor further disclosures regarding the associated capital raising transaction.<\/p> <\/div>
Key Points<\/h3>
- Company: Excite Technology Services Ltd (ASX:EXT)<\/li>
- Proposal to issue 100,000,000 options at $0.01 exercise price, expiring 31 August 2029<\/li>
- Options issued as part-payment for capital raising services, not for cash<\/li>
- Shareholder approval required under ASX Listing Rule 7.1, with meeting planned for 31 August 2026<\/li>
- Proposed issue date: 31 August 2026, subject to shareholder approval<\/li>
- Each option converts into one fully paid ordinary EXT share upon exercise<\/li>
- Options represent a new class of securities not quoted on ASX; no quotation sought for the options themselves<\/li>
- Investors should review the companion announcement for further details on the capital raising transaction<\/li>
<\/ul>
<\/div>
Details of the 100 Million Option Grant as Capital Raising Fee<\/h2>
Excite Technology Services has submitted an Appendix 3B to ASX, notifying the market of the proposed securities issue. The filing confirms EXT plans to issue up to 100 million options as partial consideration for capital raising services provided or to be provided. Importantly, no cash payment is involved; instead, the options serve as non-cash remuneration for the party assisting with the fundraising.<\/p>
The options have an exercise price of $0.01 each and expire on 31 August 2029, providing a 36-month exercise period from the proposed issue date of 31 August 2026. Full exercise of all options would result in the issuance of 100 million new fully paid ordinary shares, generating $1 million in exercise proceeds. The filing does not disclose the capital raising adviser or lead manager, referring readers to a companion announcement released concurrently.<\/p>
Requirement for Shareholder Approval Under ASX Listing Rule 7.1<\/h2>
Issuance of the options is contingent on shareholder approval under ASX Listing Rule 7.1, which limits the amount of securities a listed company can issue within 12 months without consent, typically to 15% of existing share capital. By seeking shareholder approval, EXT can issue the options outside this limit, allowing greater flexibility.<\/p>
The company estimates the shareholder meeting to approve the issue will occur on 31 August 2026, coinciding with the proposed issue date. This suggests EXT plans to hold a general or extraordinary meeting by that date. The date is noted as an estimate and may be subject to change. Until approval is secured, the options cannot be issued unconditionally.<\/p>
Implications of the $0.01 Exercise Price and Potential Dilution<\/h2>
The low exercise price of $0.01 is typical for options granted as adviser fees in small-cap capital raisings. These options have intrinsic value if EXT's share price exceeds $0.01 during the 36-month exercise period, incentivizing option holders to exercise.<\/p>
Issuance of 100 million new shares upon full exercise could dilute existing shareholders. The filing does not specify EXT's current total shares on issue, so the exact dilution percentage cannot be determined from this update alone. Investors should consult EXT's latest Appendix 3B or annual report for current capital structure details.<\/p>
New Security Class and Lack of ASX Quotation for Options<\/h2>
The options constitute a new class of securities not currently quoted or recorded by ASX. EXT will not seek ASX quotation for these options, meaning they will remain unlisted and non-tradable on the exchange. Holders can only exercise the options or hold them until expiry.<\/p>
Upon exercise, holders receive ordinary fully paid EXT shares, which are listed and traded on ASX under the ticker EXT. Each option converts into one ordinary share. There is no indication that the options will be subject to voluntary escrow, so shares issued upon exercise may not be locked up, though other restrictions might apply depending on the capital raising terms.<\/p>
Companion Announcement to Provide Additional Capital Raising Details<\/h2>
The Appendix 3B references a companion announcement released concurrently, which contains further information on fees, costs, and the capital raising transaction. This is standard when securities notifications accompany capital raising disclosures.<\/p>
Investors and analysts seeking comprehensive details on EXT's fundraising—such as the amount raised, offer terms, and adviser identity—should review the companion announcement. This Appendix 3B only outlines the mechanics of the option grant as a fee component, not the full scope of the capital raising.<\/p>
No Underwriting or Lead Manager Named for the Option Issue<\/h2>
The filing confirms no underwriting arrangement exists for this option issue, consistent with the options being issued as remuneration rather than as part of an underwritten placement. It also indicates no lead manager or broker is involved in this specific option tranche, though the companion announcement may provide broader context.<\/p>
The absence of underwriting aligns with the options serving as a fee instrument. The recipient, likely the capital raising adviser or broker, benefits if EXT's share price rises above $0.01 within the exercise period, aligning their interests with those of the company and shareholders.<\/p>
Context on Excite Technology Services’ Fundraising Efforts<\/h2>
Excite Technology Services Ltd operates in the technology services sector and is listed on ASX under ticker EXT. The engagement of a capital raising adviser and the issuance of low-exercise-price options with a three-year term indicate EXT is pursuing new funding, a common step for smaller ASX-listed tech companies to support operations, development, or expansion.<\/p>
The filing does not disclose the total capital raise amount, use of proceeds, or financial guidance. Such information, if available, would appear in the companion announcement or related documents. Thus, the full strategic rationale behind the fundraising remains unclear from this update alone.<\/p>
Timeline for Shareholder Meeting and Option Issuance<\/h2>
EXT targets 31 August 2026 as both the estimated shareholder approval date and the proposed option issue date. This suggests the company plans to issue the options immediately upon receiving shareholder consent, with no delay.<\/p>
This date also marks the start of the options' 36-month life, expiring on 31 August 2029. Shareholders will need to evaluate whether granting 100 million low-exercise-price options as a fee is fair and reasonable relative to the services provided and expected fundraising outcome.<\/p>
What Shareholders Should Watch Next<\/h2>
Shareholders should look out for the notice of meeting ahead of the 31 August 2026 general meeting. This document will detail the resolution to approve the option issue, include any independent directors' recommendations, and provide further information about the capital raising adviser and transaction. It may also contain an independent expert’s report if required.<\/p>
Following the meeting, investors should review the companion announcement, which may already be available on the ASX platform. Disclosure of the capital raise size, pricing, and structure will be critical to understanding the full implications of the option grant and whether it constitutes appropriate remuneration. The immediate share price impact of this filing was not evident from publicly available information.<\/p>
Details of the 100 Million Option Grant as Capital Raising Fee<\/h2>
Excite Technology Services has submitted an Appendix 3B to ASX, notifying the market of the proposed securities issue. The filing confirms EXT plans to issue up to 100 million options as partial consideration for capital raising services provided or to be provided. Importantly, no cash payment is involved; instead, the options serve as non-cash remuneration for the party assisting with the fundraising.<\/p>
The options have an exercise price of $0.01 each and expire on 31 August 2029, providing a 36-month exercise period from the proposed issue date of 31 August 2026. Full exercise of all options would result in the issuance of 100 million new fully paid ordinary shares, generating $1 million in exercise proceeds. The filing does not disclose the capital raising adviser or lead manager, referring readers to a companion announcement released concurrently.<\/p>
Requirement for Shareholder Approval Under ASX Listing Rule 7.1<\/h2>
Issuance of the options is contingent on shareholder approval under ASX Listing Rule 7.1, which limits the amount of securities a listed company can issue within 12 months without consent, typically to 15% of existing share capital. By seeking shareholder approval, EXT can issue the options outside this limit, allowing greater flexibility.<\/p>
The company estimates the shareholder meeting to approve the issue will occur on 31 August 2026, coinciding with the proposed issue date. This suggests EXT plans to hold a general or extraordinary meeting by that date. The date is noted as an estimate and may be subject to change. Until approval is secured, the options cannot be issued unconditionally.<\/p>
Implications of the $0.01 Exercise Price and Potential Dilution<\/h2>
The low exercise price of $0.01 is typical for options granted as adviser fees in small-cap capital raisings. These options have intrinsic value if EXT's share price exceeds $0.01 during the 36-month exercise period, incentivizing option holders to exercise.<\/p>
Issuance of 100 million new shares upon full exercise could dilute existing shareholders. The filing does not specify EXT's current total shares on issue, so the exact dilution percentage cannot be determined from this update alone. Investors should consult EXT's latest Appendix 3B or annual report for current capital structure details.<\/p>
New Security Class and Lack of ASX Quotation for Options<\/h2>
The options constitute a new class of securities not currently quoted or recorded by ASX. EXT will not seek ASX quotation for these options, meaning they will remain unlisted and non-tradable on the exchange. Holders can only exercise the options or hold them until expiry.<\/p>
Upon exercise, holders receive ordinary fully paid EXT shares, which are listed and traded on ASX under the ticker EXT. Each option converts into one ordinary share. There is no indication that the options will be subject to voluntary escrow, so shares issued upon exercise may not be locked up, though other restrictions might apply depending on the capital raising terms.<\/p>
Companion Announcement to Provide Additional Capital Raising Details<\/h2>
The Appendix 3B references a companion announcement released concurrently, which contains further information on fees, costs, and the capital raising transaction. This is standard when securities notifications accompany capital raising disclosures.<\/p>
Investors and analysts seeking comprehensive details on EXT's fundraising—such as the amount raised, offer terms, and adviser identity—should review the companion announcement. This Appendix 3B only outlines the mechanics of the option grant as a fee component, not the full scope of the capital raising.<\/p>
No Underwriting or Lead Manager Named for the Option Issue<\/h2>
The filing confirms no underwriting arrangement exists for this option issue, consistent with the options being issued as remuneration rather than as part of an underwritten placement. It also indicates no lead manager or broker is involved in this specific option tranche, though the companion announcement may provide broader context.<\/p>
The absence of underwriting aligns with the options serving as a fee instrument. The recipient, likely the capital raising adviser or broker, benefits if EXT's share price rises above $0.01 within the exercise period, aligning their interests with those of the company and shareholders.<\/p>
Context on Excite Technology Services’ Fundraising Efforts<\/h2>
Excite Technology Services Ltd operates in the technology services sector and is listed on ASX under ticker EXT. The engagement of a capital raising adviser and the issuance of low-exercise-price options with a three-year term indicate EXT is pursuing new funding, a common step for smaller ASX-listed tech companies to support operations, development, or expansion.<\/p>
The filing does not disclose the total capital raise amount, use of proceeds, or financial guidance. Such information, if available, would appear in the companion announcement or related documents. Thus, the full strategic rationale behind the fundraising remains unclear from this update alone.<\/p>
Timeline for Shareholder Meeting and Option Issuance<\/h2>
EXT targets 31 August 2026 as both the estimated shareholder approval date and the proposed option issue date. This suggests the company plans to issue the options immediately upon receiving shareholder consent, with no delay.<\/p>
This date also marks the start of the options' 36-month life, expiring on 31 August 2029. Shareholders will need to evaluate whether granting 100 million low-exercise-price options as a fee is fair and reasonable relative to the services provided and expected fundraising outcome.<\/p>
What Shareholders Should Watch Next<\/h2>
Shareholders should look out for the notice of meeting ahead of the 31 August 2026 general meeting. This document will detail the resolution to approve the option issue, include any independent directors' recommendations, and provide further information about the capital raising adviser and transaction. It may also contain an independent expert’s report if required.<\/p>
Following the meeting, investors should review the companion announcement, which may already be available on the ASX platform. Disclosure of the capital raise size, pricing, and structure will be critical to understanding the full implications of the option grant and whether it constitutes appropriate remuneration. The immediate share price impact of this filing was not evident from publicly available information.<\/p>
